Lumipulse® G sTREM2
Immunoassay to be used with the automated LUMIPULSE® G System for the quantitative measurement of soluble triggering receptor expressed on myeloid cells 2 (sTREM2) in human serum, plasma, and cerebrospinal fluid (CSF).
This product is not for use in diagnostic procedures, for ‘Research Use Only’.
Product number 81656
Product number 81657
Click here to navigate
- Contact sales for information
- Documentation
- Insights
- Alzheimer's disease
- Product inquiry
- Related products
-
Documentation
Browse regulatory documents for this product
Create a (free!) eServices account and start browsing all product documentation right away.
Get access to this section and more
Create a free eServices account now and instantly access multiple digital resources:
- Product documentation
- Selected scientific posters
- Product leaflets
- How-to videos and more…
-
Insights
Nov 13, 2024Video - Alzheimer's awareness redefined
Follow the journey of the Sullivan family and leading Alzheimer’s Neurologist and Researcher Dr. David Greeley as they introduce and explain these...
Feb 20, 2024Publication - Serum and cerebrospinal fluid neurofilament light chains measured by SIMOA™, Ella™, and Lumipulse™ in multiple sclerosis naïve patients
We would like to draw your attention to a first publication on our Lumipulse® G NfL solution. In this article you will find a method comparison of CSF...
Dec 1, 2023CTAD 2023 – Spotlight on recent advances in blood-based biomarkers for Alzheimer’s disease
Both fluid and imaging biomarkers provide biological evidence for the underlying etiology of cognitive impairment. The core fluid biomarkers of...
-
Product inquiry
-
Related products